| 000 | 01485 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513040510.0 | ||
| 264 | 0 | _c19931020 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/0049-3848(93)90082-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpiecker, M | |
| 245 | 0 | 0 |
_aSynergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo. _h[electronic resource] |
| 260 |
_bThrombosis research _cJun 1993 |
||
| 300 |
_a405-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdenylyl Cyclase Inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xmetabolism |
| 650 | 0 | 4 |
_aIloprost _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMolsidomine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aDarius, H | |
| 700 | 1 | _aMeyer, J | |
| 773 | 0 |
_tThrombosis research _gvol. 70 _gno. 5 _gp. 405-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0049-3848(93)90082-y _zAvailable from publisher's website |
| 999 |
_c7690416 _d7690416 |
||